A phase III open-label extension study to evaluate long-term safety and efficacy of PRM-151 in patients with idiopathic pulmonary fibrosis (IPF)

  • Li, Xun (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/04/22 → 4/04/27

Keywords

  • phase 3 study
  • treatment safety
  • treatment efficacy
  • pulmonary fibrosis

Clinical Trial Phase

  • Phase III (a & b)